AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Explore the best credit cards that provide cash back without any fees. Start saving more on your purchases!
26,647 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
Rockwell Medical is a niche player in renal care. This analysis breaks down rockwell medical (rmti) earnings, what th...
Amazon's liquidity position is tightening as it pours billions into AI infrastructure. Investors pore over cash metri...
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...
Investors rotated into AI infrastructure plays this week, lifting Argan and similar names. This piece breaks down the...
Can Lumen Technologies stock your journey toward wealth? This article breaks down the company’s shift toward AI infra...
Ciena’s stock faced a sharp one-day retreat even after solid results, revealing how AI infrastructure optimism can cl...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
General Dynamics outpaced Lockheed Martin in Q1 2026 results, driven by submarines and jets. The gap in backlogs high...
The crypto industry is cooling as funding tightens and demand wavers. Syndicate Labs shuts down amid a wave of cost c...
Take-Two is set to release Q4 results as GTA VI heads toward a highly anticipated November debut. The company plans a...